Medicare Enrolled
Dr. Abhishek Gupta, DO
Pain Medicine · Stony Brook, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gupta from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gupta?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gupta
Dr. Abhishek Gupta is a pain medicine specialist in Stony Brook, NY, with 12 years of NPI registration. Based on federal Medicare data, Dr. Gupta performed 6,902 Medicare services across 1,968 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gupta received a total of $29,767 from 31 pharmaceutical and/or device companies across 432 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gupta is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years in practice
▲ Top 7% volume in NY
$29,767 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,902
Medicare services
Top 7% in NY for pain medicine
1,968
Unique beneficiaries
$56
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~575 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,430 | $0 | $2 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
1,153 | $1 | $6 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,112 | $113 | $360 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
257 | $75 | $387 |
| Fluoroscopic guidance for needle placement Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure. |
249 | $113 | $350 |
| Midazolam injection, per 1 mg Administration of midazolam hydrochloride, a sedative medication, measured in 1 mg increments. |
245 | $0 | $4 |
| Orthovisc intra-articular injection An injection of hyaluronan or its derivative into a joint space to provide lubrication and cushioning. |
235 | $100 | $575 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
216 | $150 | $447 |
| Lidocaine HCl injection for IV infusion, 10 mg Administration of a 10 mg dose of lidocaine hydrochloride via intravenous infusion. |
162 | $0 | $8 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
103 | $57 | $570 |
| Extended-release steroid injection (Zilretta) An injection of triamcinolone acetonide using a preservative-free, extended-release microsphere formulation. The dosage is measured in milligrams. |
101 | $13 | $629 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
82 | $191 | $1,839 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
66 | $252 | $1,652 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
56 | $253 | $3,398 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
56 | $124 | $1,425 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
53 | $421 | $2,778 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
53 | $235 | $1,221 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
45 | $115 | $447 |
| Spinal injection with imaging guidance A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location. |
43 | $251 | $1,665 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
41 | $278 | $2,546 |
| Minimally invasive spine decompression, lower spine A minimally invasive procedure to remove bone from the lower spine to relieve pressure on nerve tissue, guided by imaging and accessed through the skin. |
24 | $559 | $5,025 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
24 | $104 | $650 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
23 | $76 | $246 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
19 | $50 | $550 |
| Knee nerve block injection with imaging guidance An injection of anesthetic and/or steroid medication into a nerve branch of the knee, performed using imaging guidance to ensure accurate placement. |
18 | $270 | $1,520 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
18 | $268 | $2,833 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
18 | $133 | $1,111 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.3% high complexity
72.6% medium
25.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$29,767
Total received (2019-2024)
Avg $4,961/year across 6 years
Top 4% in NY for pain medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
31
Companies
432
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,726 (62.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$9,749 (32.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,293 (4.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$7,835
2023
$4,499
2022
$6,885
2021
$4,840
2020
$2,248
2019
$3,460
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Stryker Corporation
$2,722
Vertos Medical, Inc.
$2,585
Nevro Corp.
$942
Boston Scientific Corporation
$516
PAINTEQ LLC
$258
Saluda Medical Americas, Inc.
$196
Curonix LLC
$161
SPR Therapeutics, Inc
$154
Collegium Pharmaceutical, Inc.
$119
Ossur Americas, Inc.
$44
ABBVIE INC.
$42
Abbott Laboratories
$38
Medtronic, Inc.
$22
ConvaTec Inc.
$22
Alnylam Pharmaceuticals Inc.
$15
Top 3 companies account for 79.8% of 2024 payments
All-time payments by company (2019-2024) ›
Nevro Corp.
$7,643
Vertos Medical, Inc.
$7,290
Stryker Corporation
$3,086
Abbott Laboratories
$2,103
Relievant Medsystems, Inc.
$1,872
BAUDAX BIO INC.
$1,293
Medtronic, Inc.
$1,197
Medtronic USA, Inc.
$1,109
Boston Scientific Corporation
$866
SPR Therapeutics, Inc
$644
Baudax Bio Inc.
$533
PAINTEQ LLC
$373
Collegium Pharmaceutical, Inc.
$313
MML US, Inc.
$262
Saluda Medical Americas, Inc.
$196
Curonix LLC
$161
SI-BONE, INC.
$144
Esperion Therapeutics, Inc.
$125
Stratus Medical, LLC
$83
Horizon Therapeutics plc
$78
AcelRx Pharmaceuticals, Inc.
$77
Stimwave Technologies Incorporated
$48
Chiesi USA, Inc.
$45
Ossur Americas, Inc.
$44
ABBVIE INC.
$42
GRT US Holding, Inc.
$36
SI-BONE, Inc.
$26
ConvaTec Inc.
$22
BOSTON SCIENTIFIC CORPORATION
$21
Acacia Pharma Inc
$18
Alnylam Pharmaceuticals Inc.
$15
Top 3 companies account for 60.5% of all-time payments
Associated products mentioned in payments ›
ADAPTIVESTIM · ANJESO · AQUACEL AG+ EXTRA · AUGMENT INJECTABLE · Axium INS DRG IPG · BYFAVO · Belbuca · CD HORIZON · CLEVIPREX · DSUVIA · Evoke · GENERAL - PAIN MANAGEMENT · GIVLAARI · General - Pain Management · IFUSE IMPLANT · INFINION · INFINITY OCT System · INTELLIS · INTELLIS ADAPTIVESTIM · Intracept · IonicRF Generator · MILD DEVICE KIT · Miami J · NEXLIZET · Nimbus · Nucynta · Octrode SCS Leads · Omnia · PAINTEQ · PENNSAID · PENTA · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PROCLAIM · Proclaim Family of SCS IPGs · Proclaim IPG · QULIPTA · Qutenza · RESTORE · RIALTO · ReActiv8 · SPECTRA WAVEWRITER · SPINEJACK · SPRINT PNS System · SYNCHROMED · Senza · Senza Spinal Cord Stimulation System · UBRELVY · XTAMPZA · iFuse Implant · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (63%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for pain medicine in NY.
Geographic Context
Pain medicines within 10 mi
34
Per 100K population
2.2
County median income
$128,329
Nearest hospital
SUNY/STONY BROOK UNIVERSITY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Gupta is a clinical cardiology specialist, with above-average Medicare volume (top 7% in NY), with low-engagement industry engagement in the top 4% of NY peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Gupta experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Gupta performed 2,430 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gupta receive payments from pharmaceutical companies?
Yes. Dr. Gupta received a total of $29,767 from 31 companies across 432 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gupta's costs compare to other pain medicines in Stony Brook?
Dr. Gupta's average Medicare payment per service is $56. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gupta) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Pain Medicines in Stony Brook
Browse pain medicines in Stony Brook ranked by procedure volume and transparency data.
Highest volume
Top Pain Medicines in NY
Pain medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pain Medicines in NY
Which NY pain medicines receive the most from drug and device companies.
By company
Nevro Corp. Payments to Doctors
See all physicians who received payments from Nevro Corp.
By company
Vertos Medical, Inc. Payments to Doctors
See all physicians who received payments from Vertos Medical, Inc.
By company
Stryker Corporation Payments to Doctors
See all physicians who received payments from Stryker Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology